- Home
- DAKT vs ORIC Comparison
DAKT vs ORIC Comparison
Compare DAKT & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DAKT
- ORIC
- Stock Information
- Founded
- DAKT 1968
- ORIC 2014
- Country
- DAKT United States
- ORIC United States
- Employees
- DAKT N/A
- ORIC N/A
- Industry
- DAKT Office Equipment/Supplies/Services
- ORIC Biotechnology: Pharmaceutical Preparations
- Sector
- DAKT Industrials
- ORIC Health Care
- Exchange
- DAKT Nasdaq
- ORIC Nasdaq
- Market Cap
- DAKT 710.0M
- ORIC 362.9M
- IPO Year
- DAKT 1994
- ORIC 2020
- Fundamental
- Price
- DAKT $16.21
- ORIC $11.10
- Analyst Decision
- DAKT Strong Buy
- ORIC Strong Buy
- Analyst Count
- DAKT 1
- ORIC 9
- Target Price
- DAKT $26.00
- ORIC $18.29
- AVG Volume (30 Days)
- DAKT 521.6K
- ORIC 964.9K
- Earning Date
- DAKT 09-03-2025
- ORIC 08-11-2025
- Dividend Yield
- DAKT N/A
- ORIC N/A
- EPS Growth
- DAKT N/A
- ORIC N/A
- EPS
- DAKT N/A
- ORIC N/A
- Revenue
- DAKT $756,477,000.00
- ORIC N/A
- Revenue This Year
- DAKT $9.98
- ORIC N/A
- Revenue Next Year
- DAKT $6.80
- ORIC N/A
- P/E Ratio
- DAKT N/A
- ORIC N/A
- Revenue Growth
- DAKT N/A
- ORIC N/A
- 52 Week Low
- DAKT $10.24
- ORIC $3.90
- 52 Week High
- DAKT $19.89
- ORIC $14.67
- Technical
- Relative Strength Index (RSI)
- DAKT 59.38
- ORIC 66.82
- Support Level
- DAKT $15.87
- ORIC $10.42
- Resistance Level
- DAKT $16.78
- ORIC $11.50
- Average True Range (ATR)
- DAKT 0.83
- ORIC 0.62
- MACD
- DAKT 0.11
- ORIC -0.03
- Stochastic Oscillator
- DAKT 78.02
- ORIC 83.30
About DAKT Daktronics Inc.
Daktronics Inc designs and manufactures electronic scoreboards, programmable display systems, and large-screen video displays for sporting, commercial, and transportation applications. It is engaged in a full range of activities: marketing and sales, engineering and product design and development, manufacturing, technical contracting, professional services, and customer service and support. The company offers a complete line of products, from small scoreboards and electronic displays to large multimillion-dollar video display systems as well as related control, timing, and sound systems. The company has five reportable segments: Commercial, Live Events, High School Park and Recreation, Transportation, and International. The company makes the majority of its revenue from Live events.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.